| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.13B | 1.14B | 1.13B | 1.10B | 955.04M | 898.40M |
| Gross Profit | 769.22M | 762.76M | 778.62M | 775.93M | 685.46M | 637.68M |
| EBITDA | 698.90M | 735.49M | 708.81M | 640.75M | 553.33M | 538.41M |
| Net Income | 322.96M | 210.97M | 212.24M | 232.62M | 628.14M | 187.10M |
Balance Sheet | ||||||
| Total Assets | 10.99B | 10.90B | 11.40B | 10.80B | 10.58B | 10.00B |
| Cash, Cash Equivalents and Short-Term Investments | 277.65M | 193.66M | 510.16M | 347.38M | 441.55M | 759.47M |
| Total Debt | 4.72B | 4.73B | 5.05B | 4.39B | 4.19B | 4.02B |
| Total Liabilities | 5.31B | 5.29B | 5.74B | 5.12B | 4.89B | 4.72B |
| Stockholders Equity | 5.47B | 5.38B | 5.43B | 5.44B | 5.44B | 5.03B |
Cash Flow | ||||||
| Free Cash Flow | 454.62M | 40.17M | 58.77M | 5.63M | -1.28B | -160.47M |
| Operating Cash Flow | 565.47M | 541.15M | 602.59M | 592.24M | 516.40M | 455.59M |
| Investing Cash Flow | -102.42M | -225.04M | -800.40M | -553.19M | -747.88M | -542.13M |
| Financing Cash Flow | -716.04M | -660.58M | 360.60M | -118.75M | -164.57M | 833.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $5.08B | 15.67 | 5.94% | 5.06% | 0.77% | 62.58% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | $3.16B | 24.94 | 5.37% | 6.75% | -2.10% | -13.30% | |
63 Neutral | $4.32B | 74.19 | 1.26% | 4.89% | 16.38% | 3.60% | |
57 Neutral | $7.42B | 8.47 | 15.97% | 1.99% | 2.41% | ― | |
54 Neutral | $2.15B | 59.33 | 1.04% | 6.35% | -0.12% | ― | |
51 Neutral | $3.86B | ― | 0.61% | 6.13% | 8.60% | ― |
Kilroy Realty’s recent earnings call painted a picture of a robust quarter, characterized by impressive leasing activity, particularly in San Francisco and the life science sector. The company strategically enhanced its portfolio through acquisitions and sales, although it faces challenges with upcoming lease expirations and the need to re-lease vacated spaces. Despite these hurdles, the positive aspects, especially in leasing, overshadow the challenges.
Kilroy Realty Corporation is a leading U.S. real estate investment trust (REIT) specializing in office, life science, and mixed-use projects, with a strong focus on sustainability and innovation across major markets including San Francisco, Los Angeles, Seattle, San Diego, and Austin.
On October 27, 2025, Kilroy Realty Corporation announced its financial results for the third quarter ending September 30, 2025, reporting revenues of $279.7 million and a significant increase in net income to $156.2 million compared to the previous year. The company highlighted strong leasing activity, particularly at Kilroy Oyster Point Phase 2, and completed significant acquisition and disposition activities, including the purchase of Maple Plaza in Los Angeles and the sale of a campus in Silicon Valley. Kilroy also updated its full-year guidance for funds from operations, reflecting an optimistic outlook.
The most recent analyst rating on (KRC) stock is a Hold with a $44.00 price target. To see the full list of analyst forecasts on Kilroy Realty stock, see the KRC Stock Forecast page.
On August 8, 2025, Kilroy Realty Corporation completed a public offering of $400 million in senior notes due in 2035, with an interest rate of 5.875%. This strategic financial move aims to strengthen the company’s capital structure and support its ongoing operations and growth initiatives. Additionally, the company filed a new registration statement to facilitate its ‘at-the-market’ equity offering, allowing for the sale of up to $500 million in common stock, enhancing its financial flexibility and market presence.
The most recent analyst rating on (KRC) stock is a Buy with a $38.00 price target. To see the full list of analyst forecasts on Kilroy Realty stock, see the KRC Stock Forecast page.
Kilroy Realty Corporation is a prominent real estate investment trust (REIT) specializing in the development, acquisition, and management of office, life science, and mixed-use properties across major U.S. cities, with a strong commitment to sustainability and innovation in the real estate sector.
The recent earnings call for Kilroy Realty Corporation conveyed a generally positive sentiment, underscored by robust leasing activity and strategic capital recycling efforts, particularly in high-demand markets such as San Francisco and San Diego. However, the company is facing challenges with occupancy declines and negative re-leasing spreads, alongside broader hurdles in the life science ecosystem.